share_log

This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

這位GE Vernova分析師開始看好的分析報告; 這是週一的前五個評級開始。
Benzinga ·  10/21 21:01

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

華爾街頂級分析師改變了對這些頂級公司的展望。如需查看包括升級和降級在內的所有分析師評級變化的完整視圖,請參閱我們的分析師評級頁面。

  • Deutsche Bank analyst Nicole Deblase initiated coverage on GE Vernova Inc. (NYSE:GEV) with a Buy rating and announced a price target of $354. GE Vernova shares closed at $272.72 on Friday. See how other analysts view this stock.
  • Keybanc analyst Tim Rezvan initiated coverage on BKV Corporation (NYSE:BKV) with an Overweight rating and announced a price target of $23. Prologis shares closed at $18.45 on Friday. See how other analysts view this stock.
  • Jefferies analyst Andrew Tsai initiated coverage on Sarepta Therapeutics, Inc. (NASDAQ:SRPT) with a Buy rating and announced a price target of $165. Sarepta Therapeutics shares closed at $127.08 on Friday. See how other analysts view this stock.
  • Benchmark analyst Josh Sullivan initiated coverage on ESCO Technologies Inc. (NYSE:ESE) with a Buy rating and announced a price target of $150. ESCO Technologies shares closed at $126.20 on Friday. See how other analysts view this stock.
  • Truist Securities analyst David Macdonald initiated coverage on Guardian Pharmacy Services, Inc. (NYSE:GRDN) with a Buy rating and announced a price target of $22. Guardian Pharmacy shares closed at $17.68 on Friday. See how other analysts view this stock.
  • 德意志銀行分析師Nicole Deblase發起了對GE Vernova Inc.(紐交所:GEV)的研究報告,並給出了買入評級,目標股價爲354美元。GE Vernova股票在週五收盤價爲272.72美元。看看其他分析師對這隻股票的看法。
  • Keybanc分析師tim Rezvan對BKV Corporation(紐交所:BKV)進行了覆蓋,並給出了超配評級,目標股價爲23美元。Prologis股票在週五收盤價爲18.45美元。看看其他分析師對這隻股票的看法。
  • Jefferies分析師Andrew Tsai對sarepta therapeutics, Inc.(納斯達克:SRPT)進行了覆蓋,並給出了買入評級,目標股價爲165美元。Sarepta Therapeutics股票在週五收盤價爲127.08美元。看看其他分析師對這隻股票的看法。
  • Benchmark分析師Josh Sullivan對ESCO Technologies Inc.(紐交所:ESE)進行了覆蓋,並給出了買入評級,目標股價爲150美元。ESCO Technologies股票在週五收盤價爲126.20美元。看看其他分析師對這隻股票的看法。
  • Truist Securities分析師David Macdonald對Guardian Pharmacy Services, Inc.(紐交所:GRDN)進行了覆蓋,並給出了買入評級,目標股價爲22美元。Guardian Pharmacy股票在週五收盤價爲17.68美元。看看其他分析師對這隻股票的看法。

Considering buying GEV stock? Here's what analysts think:

考慮買入GEV股票嗎?以下是分析師的看法:

  • Dow, S&P 500 Settle At Record High Levels, Record 6th Consecutive Week Of Gains: Fear Index Moves To 'Extreme Greed' Zone
  • 道瓊指數、標準普爾500指數創紀錄高點,連續第6週上漲:恐懼指數上升至'極度貪婪'區域

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論